You are browsing the Hong Kong website, Regulated by Hong Kong SFC (CE number: BJA907). Investment is risky and you must be cautious when entering the market.
香雪製藥(300147.SZ):香雪生命科學擬實施核心人員股權激勵 其考慮獨立上市
格隆匯 03-08 14:16

格隆匯 3 月 8日丨香雪製藥(300147.SZ)公佈,為快速引進和吸納高端人才,充分調動公司和子公司香雪生命科學技術(廣東)有限公司(“香雪生命科學”)管理層、研發人員及業務骨幹的工作積極性,保障核心人員穩定、積極、長期投入工作,加速推進在研產品研發進程,激勵核心人員努力奮鬥,並將自身利益與公司長遠發展緊密結合,公司擬通過香雪生命科學作為股權激勵實施主體實施核心人員的股權激勵。

香雪生命科學的設立是落實公司成為抗腫瘤藥物研發的專業公司打造全球創新的行業技術平台增強公司核心競爭力的發展戰略具體措施之一以子公司員工股權激勵的方式調動核心人員積極性,進一步強化公司在高親和性特異性T細胞免疫治療藥物和治療方法研發方面實力。香雪生命科學在符合獨立上市條件情況下考慮獨立上市。

香雪生命科學將依託於公司大平台,逐步建立獨立的研發、管理、生產體系,根據業務發展情況,逐步提高經營管理獨立性。香雪生命科學的主要業務範圍包括:細胞技術研發和應用;醫學研究和試驗發展;技術服務、技術開發、技術諮詢、技術交流、技術轉讓、技術推廣;技術進出口;貨物進出口。許可項目:藥品進出口;藥品生產。

Follow us
Find us on Facebook, Twitter , Instagram, and YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.
uSMART
Wealth Growth Made Easy
Open Account